Diagnostic Impact of Dual-Time PET/CT with 68Gallium-PSMA in Prostate Cancer and 68Gallium-DOTATOC in Neuroendocrine Tumors

Diagnostic Impact of Dual-Time PET/CT with 68Gallium-PSMA in Prostate Cancer and 68Gallium-DOTATOC in Neuroendocrine Tumors

Background: The timing of imaging for 68gallium (68Ga)-PSMA and 68Ga-DOTATOC are stated to be around 60 min post-injection (p.i.). In some lesions, late imaging (3–4 h p.i.) showed advantages. The aim of our evaluation was to demonstrate the relevance of an “early” late acquisition. Methods: We retr...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Librizzi, Damiano, Eilsberger, Friederike, Ottenthaler, Stefan, Ebrahimifard, Ali, Luster, Markus, Yousefi, Behrooz H.
Formaat: Artikel
Taal:Engels
Gepubliceerd in: Philipps-Universität Marburg 2023
Onderwerpen:
Medizin
neuroendocrine tumor
DOTATOC
PSMA
dual-time
prostate cancer
PET/CT
68gallium
Medical sciences Medicine
Online toegang:PDF Full text
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Internet

PDF Full text

Exemplaargegevens van
Plaatsingsnummer: urn:nbn:de:hebis:04-es2024-02863
Publicatiedatum: 2024-01-15
Bron: Erstveröffentlichung: Librizzi, D.; Eilsberger, F.; Ottenthaler, S.; Ebrahimifard, A.; Luster, M.; Yousefi, B.H. Diagnostic Impact of Dual-Time PET/CT with 68Gallium-PSMA in Prostate Cancer and 68Gallium-DOTATOC in Neuroendocrine Tumors. Biomedicines 2023, 11, 1052. https://doi.org/10.3390/biomedicines11041052
Downloads: 37 (2024)
Lizenz: https://creativecommons.org/licenses/by/4.0
URL naar item: https://archiv.ub.uni-marburg.de/es/2024/0286
https://doi.org/10.3390/biomedicines11041052

Gelijkaardige items